<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR56.html">Part 56
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 56.103  Circumstances in which IRB review is required.
                            </h3>
                            <p class="depth1"><em>(a)</em> Except as provided in Sec. Sec. 56.104 and 56.105, any clinical  investigation which   must meet the requirements for prior submission (as required in parts  312, 812, and 813) to the Food and Drug Administration shall not be  initiated unless that investigation has been reviewed and approved by,  and remains subject to continuing review by, an IRB meeting the  requirements of this part.</p><p class="depth1"><em>(b)</em> Except as provided in Sec. Sec. 56.104 and 56.105, the Food and  Drug Administration may decide not to consider in support of an  application for a research or marketing permit any data or information  that has been derived from a clinical investigation that has not been  approved by, and that was not subject to initial and continuing review  by, an IRB meeting the requirements of this part. The determination that  a clinical investigation may not be considered in support of an  application for a research or marketing permit does not, however,  relieve the applicant for such a permit of any obligation under any  other applicable regulations to submit the results of the investigation  to the Food and Drug Administration.</p><p class="depth1"><em>(c)</em> Compliance with these regulations will in no way render  inapplicable pertinent Federal, State, or local laws or regulations.  [46 FR 8975, Jan. 27, 1981; 46 FR 14340, Feb. 27, 1981]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
